In addition, in a mice model of PAH with knockout of cyclooxygenase 2 (COX 2), ifetroban inhibited the effect of deleting the COX-2 gene, diminishing the hypoxia-induced rise in right ventricle end systolic pressure and intravascular thrombosis [57]. The gene discussed is PTGS2; the disease is pulmonary arterial hypertension.